Randomized Controlled Trial of Preconception Interventions in Infertile Women With Polycystic Ovary Syndrome
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
CONTEXT: Lifestyle modification is recommended in women with polycystic ovary syndrome (PCOS) prior to conception but there are few randomized trials to support its implementation or benefit. OBJECTIVE: This study aimed to determine the relative efficacy of preconception intervention on reproductive and metabolic abnormalities in overweight/obese women with PCOS. DESIGN, SETTING, AND PARTICIPANTS: This was a randomized controlled trial of preconception and infertility treatment at Academic Health Centers in women with infertility due to PCOS, age 18-40 y and body mass index 27-42 kg/m(2). INTERVENTION: Women were randomly assigned to receive either 16 weeks of 1) continuous oral contraceptive pills (OCPs) (ethinyl estradiol 20 mcg/1 mg norethindrone acetate) ("OCP"); 2) lifestyle modification consisting of caloric restriction with meal replacements, weight loss medication (either sibutramine, or orlistat), and increased physical activity to promote a 7% weight loss ("Lifestyle"); or 3) combined treatment with both OCP and lifestyle modification ("Combined"). After preconception intervention, women underwent standardized ovulation induction with clomiphene citrate and timed intercourse for four cycles. Pregnancies were followed with trimester visits until delivery. MAIN OUTCOME MEASURES: Weight, ovulation, and live birth were measured. RESULTS: We consented 216 and randomly assigned 149 women (Lifestyle: n = 50; OCP: n = 49; Combined: n = 50). We achieved significant weight loss with both Lifestyle (mean weight loss, -6.2%; 95% confidence interval (CI), -7.4--5.0; and Combined (mean weight loss, -6.4%; 95% CI, -7.6--5.2) compared with baseline and OCP (both P < .001). There was a significant increase in the prevalence of metabolic syndrome at the end of preconception treatment compared with baseline within OCP (odds ratio [OR, 2.47; 95% CI, 1.42-4.27) whereas no change in metabolic syndrome was detected in the Lifestyle (OR, 1.18; 95% CI, 0.63-2.19) or Combined (OR, 0.72; 95% CI, 0.44-1.17) groups. Cumulative ovulation rates were superior after weight loss: OCP, 46%; Lifestyle, 60%; and Combined, 67% (P < .05). Live birth rates were OCP, 12%; Lifestyle, 26%; and Combined, 24% (P = .13). CONCLUSIONS: A preconception weight loss intervention eliminates the adverse metabolic oral contraceptive effects and, compared with oral contraceptive pretreatment, leads to higher ovulation rates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Weight reduction is the most important first-line treatment in restoring ovulation in women with PCOS and obesity (Hoeger et al., 2004;Legro et al., 2015).”
From Improvements in PCOS characteristics and phenotype severity during a randomized controlled lifestyle intervention (2021) · cites this paper as Legro et al., 2015
Experimental — accuracy not yet measuredIn the citing paper
“Previous lifestyle intervention studies in women with PCOS also demonstrated improvements in menstrual cycle length and ovulation rates (Thomson et al., 2008;Moran andTeede, 2009, Legro et al., 2015;Oberg et al., 2019).”
From Improvements in PCOS characteristics and phenotype severity during a randomized controlled lifestyle intervention (2021) · cites this paper as Legro et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
World Health Organization reference values for human semen characteristics*‡
Cooper, T. G., Noonan, E., von Eckardstein, S., Auger, J., Baker, H. W. G., Behre, H. M., Haugen, T. B., Kruger, T., Wang, C., Mbizvo, M. T., et al. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp048 · Cited by 2,827
Men at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919
Self-citationMaternal obesity and pregnancy outcome: a study of 287 213 pregnancies in London
Sebire, N., Jolly, M., Harris, J., Wadsworth, J., Joffe, M., Beard, R., Regan, L., & Robinson, S. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801670 · Cited by 1,743
A Prospective Study of Obesity and Risk of Coronary Heart Disease in Women
Manson, J. E., Colditz, G. A., Stampfer, M. J., Willett, W. C., Rosner, B., Monson, R. R., Speizer, F. E., & Hennekens, C. H. (1990) · New England Journal of Medicine · doi:10.1056/nejm199003293221303 · Cited by 1,408
Cited by
Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603
Obesity and female infertility: potential mediators of obesity's impact
Broughton, D. E., & Moley, K. H. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.01.017 · Cited by 845
“The study was underpowered to detect a difference in LBRs, but there was a trend toward benefit with the use of the lifestyle intervention (78).”
BackgroundJoham, A. E., Norman, R. J., Stener-Victorin, E., Legro, R. S., Franks, S., Moran, L. J., Boyle, J., & Teede, H. J. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00163-2 · Cited by 838
Self-citationLifestyle changes in women with polycystic ovary syndrome
Lim, S. S., Hutchison, S. K., Van Ryswyk, E., Norman, R. J., Teede, H. J., & Moran, L. J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007506.pub4 · Cited by 725
Martin, K. A., Chang, R. J., Ehrmann, D. A., Ibanez, L., Lobo, R. A., Rosenfield, R. L., Shapiro, J., Montori, V. M., & Swiglo, B. A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2437 · Cited by 512
Stener-Victorin, E., Teede, H., Norman, R. J., Legro, R., Goodarzi, M. O., Dokras, A., Laven, J., Hoeger, K., & Piltonen, T. T. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00511-3 · Cited by 495
“Preconception weight loss through lifestyle interventions or bariatric surgery may improve ovulation, enhance natural pregnancy rates 242,256 , and may increase ovulation rates with first-line treatments 257 .”
Self-citationCharacteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics
Glueck, C. J., & Goldenberg, N. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.002 · Cited by 442
Endometrial function in women with polycystic ovary syndrome: a comprehensive review
Palomba, S., Piltonen, T. T., & Giudice, L. C. (2021) · Human Reproduction Update · doi:10.1093/humupd/dmaa051 · Cited by 372
Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists
Cena, H., Chiovato, L., & Nappi, R. E. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa285 · Cited by 356
“Although the study was not powered to detect a difference in LBR, a trend toward benefit with the use of the lifestyle intervention was documented (40).”
MethodMartin, K. A., Anderson, R. R., Chang, R. J., Ehrmann, D. A., Lobo, R. A., Murad, M. H., Pugeat, M. M., & Rosenfield, R. L. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00241 · Cited by 339
“However, lifestyle changes should not be considered a primary therapy for hirsutism, as their impact is not clinically significant, particularly when compared with OCs (50).”
BackgroundInfluentialEnvironment, lifestyle, and female infertility
Bala, R., Singh, V., Rajender, S., & Singh, K. (2021) · Reproductive Sciences · doi:10.1007/s43032-020-00279-3 · Cited by 242
Physiological Aspects of Female Fertility: Role of the Environment, Modern Lifestyle, and Genetics
Hart, R. J. (2016) · Physiological Reviews · doi:10.1152/physrev.00023.2015 · Cited by 228
Obesity and reproduction: a committee opinion
Penzias, A., Azziz, R., Bendikson, K., Falcone, T., Hansen, K., Hill, M., Jindal, S., Kalra, S., Mersereau, J., Reindollar, R., et al. (2021) · Fertility and Sterility · doi:10.1016/j.fertnstert.2021.08.018 · Cited by 222
“The OWL PCOS study was a two-site RCT that randomized 149 women with PCOS (BMI range, 27–42 kg/m(2); median, approximately 35) to one of three arms: oral contraceptive pills (OCPs); lifestyle modification; and combined OCP and lifestyle modification before infertility treatment (9).”
MethodDokras, A., Saini, S., Gibson-Helm, M., Schulkin, J., Cooney, L., & Teede, H. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.04.011 · Cited by 218
Self-citationBest, D., Avenell, A., & Bhattacharya, S. (2017) · Human Reproduction Update · doi:10.1093/humupd/dmx027 · Cited by 186
“One trial (Legro et al., 2015) recommended barrier contraception during its intervention.”
BackgroundWeight reduction intervention for obese infertile women prior to IVF: A randomized controlled trial
Einarsson, S., Bergh, C., Friberg, B., Pinborg, A., Klajnbard, A., Karlström, P.-O., Kluge, L., Larsson, I., Loft, A., Mikkelsen-Englund, A.-L., et al. (2017) · Human Reproduction · doi:10.1093/humrep/dex235 · Cited by 181
Dokras, A., Sarwer, D. B., Allison, K. C., Milman, L., Kris-Etherton, P. M., Kunselman, A. R., Stetter, C. M., Williams, N. I., Gnatuk, C. L., Estes, S. J., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1896 · Cited by 161
Self-citationLegro, R. S., Dodson, W. C., Kunselman, A. R., Stetter, C. M., Kris-Etherton, P. M., Williams, N. I., Gnatuk, C. L., Estes, S. J., Allison, K. C., Sarwer, D. B., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1659 · Cited by 155
Self-citationEnvironmental determinants of polycystic ovary syndrome
Merkin, S. S., Phy, J. L., Sites, C. K., & Yang, D. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.011 · Cited by 197
Kite, C., Lahart, I. M., Afzal, I., Broom, D. R., Randeva, H., Kyrou, I., & Brown, J. E. (2019) · Systematic Reviews · doi:10.1186/s13643-019-0962-3 · Cited by 155
The Risks Associated With Obesity in Pregnancy
Stubert, J., Reister, F., Hartmann, S., & Janni, W. J. (2018) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2018.0276 · Cited by 211
Wang, R., Kim, B. V., van Wely, M., Johnson, N. P., Costello, M. F., Zhang, H., Ng, E. H. Y., Legro, R. S., Bhattacharya, S., Norman, R. J., et al. (2017) · BMJ · doi:10.1136/bmj.j138 · Cited by 133
Self-citationCostello, M. F., Misso, M. L., Balen, A., Boyle, J., Devoto, L., Garad, R. M., Hart, R., Johnson, L., Jordan, C., Legro, R. S., et al. (2019) · Human Reproduction Open · doi:10.1093/hropen/hoy021 · Cited by 122
“A randomized trial (that did not meet the inclusion criteria for this systematic review due to a change in interventions and combination of treatments) evaluated pre-conception treatment in women with PCOS with: lifestyle weight loss intervention incorporating caloric restriction, increased physical activity and pharm…”
BackgroundSelf-citationCooney, L. G., Milman, L. W., Hantsoo, L., Kornfield, S., Sammel, M. D., Allison, K. C., Epperson, C. N., & Dokras, A. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.03.028 · Cited by 117
Self-citationLegro, R. S., Hansen, K. R., Diamond, M. P., Steiner, A. Z., Coutifaris, C., Cedars, M. I., Hoeger, K. M., Usadi, R., Johnstone, E. B., Haisenleder, D. J., et al. (2022) · PLoS Medicine · doi:10.1371/journal.pmed.1003883 · Cited by 126
“Our findings may only be specific to women with unexplained infertility as opposed to other disorders such as anovulation due to polycystic ovary syndrome [18].”
BackgroundMethodInfluentialSelf-citationHunter, E., Avenell, A., Maheshwari, A., Stadler, G., & Best, D. (2021) · Obesity Reviews · doi:10.1111/obr.13325 · Cited by 96
“One study advised women in the diet and exercise intervention group to use an effective method of contraceptive(52) while another study used oral contraceptive pills in both intervention and control groups as a pre-treatment.(56) In both studies this preceded the administration of Clomiphene Citrate to induce ovulatio…”
BackgroundMethodResultInfluentialLan, L., Harrison, C. L., Misso, M., Hill, B., Teede, H. J., Mol, B. W., & Moran, L. J. (2017) · Human Reproduction · doi:10.1093/humrep/dex241 · Cited by 91
“Metabolic and hormonal profiles were reported in two studies (Palomba et al., 2010; Legro et al., 2015).”
BackgroundMethodResultInfluentialMena, G. P., Mielke, G. I., & Brown, W. J. (2019) · Human Reproduction Update · doi:10.1093/humupd/dmz013 · Cited by 122
“In half the trials (n = 9), details of exercise intensity were not provided (Lazurova et al., 2004; Karimzadeh and Javedani, 2010; Moran et al., 2011a; Nybacka et al., 2013; Sim et al., 2014b; Duval et al., 2015; Legro et al., 2015; Kaya et al., 2016; Mutsaerts et al., 2016).”
BackgroundMethodInfluentialOvulation induction in polycystic ovary syndrome: Current options
Legro, R. S. (2016) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2016.08.001 · Cited by 93
Self-citationMa, R.-L., Deng, Y., Wang, Y.-F., Zhu, S.-Y., Ding, X.-S., & Sun, A.-J. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001712 · Cited by 59
van Dijk, M. R., Koster, M. P. H., Oostingh, E. C., Willemsen, S. P., Steegers, E. A. P., & Steegers-Theunissen, R. P. M. (2020) · Journal of Medical Internet Research · doi:10.2196/15773 · Cited by 80
“Most studies regarding preconception interventions have focused on micronutrient supplementation or weight gain, for example [36,37], or on specific subgroups and disease-related conditions, such as fertility treatment [38], polycystic ovary syndrome [39], or pre-existing/gestational diabetes [40,41].”
BackgroundJiskoot, G., Dietz de Loos, A., Beerthuizen, A., Timman, R., Busschbach, J., & Laven, J. (2020) · PLOS ONE · doi:10.1371/journal.pone.0233876 · Cited by 76
“This LS intervention included behavioral modification strategies, although these specific strategies were not described [19].”
MethodOrio, F., Muscogiuri, G., Giallauria, F., Savastano, S., Bottiglieri, P., Tafuri, D., Predotti, P., Colarieti, G., Colao, A., & Palomba, S. (2016) · Clinical Endocrinology · doi:10.1111/cen.13112 · Cited by 74
Metabolic hormones are integral regulators of female reproductive health and function
Athar, F., Karmani, M., & Templeman, N. M. (2024) · Bioscience Reports · doi:10.1042/bsr20231916 · Cited by 91
“Weight loss [127–129], exercise [129–134], and bariatric surgery to limit food intake [135–140] are useful clinical tools for treating some aspects of the reproductive dysfunction associated with energy surplus.”
BackgroundEly, B. R., Clayton, Z. S., McCurdy, C. E., Pfeiffer, J. D., Needham, K. W., Comrada, L. N., & Minson, C. T. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00549.2018 · Cited by 84
Cardiometabolic Risk in PCOS: More than a Reproductive Disorder
Torchen, L. C. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0956-2 · Cited by 65
Pundir, J., Charles, D., Sabatini, L., Hiam, D., Jitpiriyaroj, S., Teede, H., Coomarasamy, A., Moran, L., & Thangaratinam, S. (2019) · Human Reproduction Update · doi:10.1093/humupd/dmy045 · Cited by 63
“Furthermore, a recent randomized trial which assessed the benefit of preconception lifestyle modification to promote weight loss followed by ovulation induction with clomiphene citrate in women with PCOS reported a significant weight loss and improvement in ovulation rates, but showed no significant difference in live…”
BackgroundDokras, A. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.10.027 · Cited by 69
Self-citationMetabolic syndrome, diet and exercise
Sousa, S. M. C. D., & Norman, R. J. (2016) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2016.01.006 · Cited by 66
Qiu, M., Tao, Y., Kuang, Y., & Wang, Y. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.08.009 · Cited by 66
Weight management interventions in women with and without PCOS: a systematic review
Kataoka, J., Tassone, E., Misso, M., Joham, A., Stener-Victorin, E., Teede, H., & Moran, L. (2017) · Nutrients · doi:10.3390/nu9090996 · Cited by 58
The last update on polycystic ovary syndrome(PCOS), diagnosis criteria, and novel treatment
Ghafari, A., Maftoohi, M., Samarin, M. E., Barani, S., Banimohammad, M., & Samie, R. (2025) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2025.100228 · Cited by 92
Wei, D., Shi, Y., Li, J., Wang, Z., Zhang, L., Sun, Y. W., Zhou, H., Xu, Y., Wu, C., Liu, L., et al. (2016) · Human Reproduction · doi:10.1093/humrep/dew325 · Cited by 62
“However, there has been increasing concern about potential adverse effects of their use on pregnancy outcomes after infertility treatment (Diamond et al., 2012; Legro et al., 2015, 2016; Jones et al., 2016).”
BackgroundSelf-citationJiskoot, G., Timman, R., Beerthuizen, A., Dietz de Loos, A., Busschbach, J., & Laven, J. (2020) · Obesity · doi:10.1002/oby.22980 · Cited by 56
Hoek, A., Wang, Z., van Oers, A. M., Groen, H., & Cantineau, A. E. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.07.020 · Cited by 65
Machado, V., Escalda, C., Proença, L., Mendes, J. J., & Botelho, J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061961 · Cited by 67
Shah, D., Patil, M., & On behalf of the National PCOS Working Group (2018) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_72_18 · Cited by 51
Ibáñez, L., del Río, L., Díaz, M., Sebastiani, G., Pozo, Ó. J., López‐Bermejo, A., & de Zegher, F. (2017) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2017.04.010 · Cited by 55
Nybacka, Å., Hellström, P. M., & Hirschberg, A. L. (2017) · Clinical Endocrinology · doi:10.1111/cen.13427 · Cited by 50
Caldwell, A. E., Gorczyca, A. M., Bradford, A. P., Nicklas, J. M., Montgomery, R. N., Smyth, H., Pretzel, S. M., Nguyen, T. B., DeSanto, K., Ernstrom, C. J., et al. (2024) · Fertility and Sterility · doi:10.1016/j.fertnstert.2024.02.038 · Cited by 57
Mono-ovulation in women with polycystic ovary syndrome: a clinical review on ovulation induction
Petersen, K. B., Pedersen, N. G., Pedersen, A. T., Lauritsen, M. P., & Freiesleben, N. L. C. (2016) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2016.03.006 · Cited by 54
“A bodyweight loss of 5–10% can induce spontaneous ovulation or increase the response to clomiphene citrate (Legro et al., 2015).”
BackgroundYao, K., Bian, C., & Zhao, X. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4642 · Cited by 49
“There is a school of thought that suggests that the metabolic abnormalities associated with IR and obesity are probably more important, mechanistically, than hyperandrogenemia for the anovulation in PCOS women (54,55).”
Kaur, I., Suri, V., Sachdeva, N. K., Rana, S. V., Medhi, B., Sahni, N., Ahire, J. J., & Singh, A. (2022) · European Journal of Nutrition · doi:10.1007/s00394-022-02959-z · Cited by 60
Patten, R. K., Pascoe, M. C., Moreno‐Asso, A., Boyle, R. A., Stepto, N. K., & Parker, A. G. (2021) · BMC Public Health · doi:10.1186/s12889-021-12280-9 · Cited by 66
“Of the included studies, only four of the interventions had full supervision by an exercise specialist [23, 33, 36, 39], three had partial supervision [22, 31, 35] and four had no supervision [24, 32, 34, 41].”
BackgroundObesity in the Workplace: Impact, Outcomes, and Recommendations
Yarborough, C. M., Brethauer, S. A., Burton, W. N., Fabius, R. J., Hymel, P. A., Kothari, S. N., Kushner, R. F., Morton, J. M., Mueller, K. L., Pronk, N. P., et al. (2018) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000001220 · Cited by 63
“These interventions have been modified for use in primary care practice,(85,86) as well as specialty medical practices, such as infertility programs.(87) Weight losses and improvements in weight-related comorbidities seen in these studies have been clinically significant for the majority of treated patients, but often…”
BackgroundSelf-citationvan Oers, A. M., Groen, H., Mutsaerts, M. A. Q., Burggraaff, J. M., Kuchenbecker, W. K. H., Perquin, D. A. M., Koks, C. A. M., van Golde, R., Kaaijk, E. M., Schierbeek, J. M., et al. (2016) · Human Reproduction · doi:10.1093/humrep/dew252 · Cited by 43
“The rate of natural conceptions was not evaluated, since infertility treatments were consecutive.(29) The choice of BMI at baseline of 35 kg/m(2) as a cut-off value for subgroup analysis was based on the International Classification of obesity in Class I (BMI 30.”
Cardiometabolic Risk in Polycystic Ovary Syndrome
Cooney, L. G., & Dokras, A. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.11.001 · Cited by 44
“The prevalence of MetS increases with use of OCPs in overweight/obese women with PCOS and can bemitigated by lifestyle modifications.(43) In summary, the risk of MetS clearly is higher in adolescent and reproductive-aged women with PCOS in several regions of the world.”
BackgroundSelf-citationWhy does Polycystic Ovary Syndrome (PCOS) Need Long-term Management?
Ruan, X., Li, M., & Mueck, A. O. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190130104922 · Cited by 43
Antimüllerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome
Feldman, R., O’Neill, K. E., Butts, S. F., & Dokras, A. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.10.009 · Cited by 46
Self-citationGestational Weight Gain in Women With Polycystic Ovary Syndrome: A Controlled Study
Kent, J., Dodson, W. C., Kunselman, A., Pauli, J., Stone, A., Diamond, M. P., Coutifaris, C., Schlaff, W. D., Alvero, R., Casson, P., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02764 · Cited by 41
Self-citationDietz de Loos, A. L. P., Jiskoot, G., Timman, R., Beerthuizen, A., Busschbach, J. J. V., & Laven, J. S. E. (2021) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2021.05.008 · Cited by 39
Stem Cell Therapies for Human Infertility: Advantages and Challenges
Wu, J., Xia, T., She, L.-P., Lin, S., & Luo, X. (2022) · Cell Transplantation · doi:10.1177/09636897221083252 · Cited by 49
Jeong, H. G., Cho, S., Ryu, K.-J., Kim, T., & Park, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-56818-4 · Cited by 51
“Although bariatric surgery is an important method to aid in weight reduction along with lifestyle modifications and medication, it is recommended that such women delay pregnancy for 1 year after surgery, to avoid fetal nutritional deficiencies 32,33 .”
MethodHow to manage weight loss in women with obesity and PCOS seeking fertility?
Hazlehurst, J. M., Singh, P., Bhogal, G., Broughton, S., & Tahrani, A. A. (2022) · Clinical Endocrinology · doi:10.1111/cen.14726 · Cited by 37
Geng, L., Yang, X., Sun, J., Ran, X., Zhou, D., Ye, M., Li, W., Wang, R., & Chen, M. (2025) · Advanced Science · doi:10.1002/advs.202412558 · Cited by 51
Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
Cignarella, A., Mioni, R., Sabbadin, C., Dassie, F., Parolin, M., Vettor, R., Barbot, M., & Scaroni, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249554 · Cited by 36
Successful weight loss interventions before in vitro fertilization: fat chance?
Norman, R. J., & Mol, B. W. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.05.029 · Cited by 38
Preconception management of women with obesity: A systematic review
Price, S., Sumithran, P., Nankervis, A. J., Permezel, M., & Proietto, J. (2018) · Obesity Reviews · doi:10.1111/obr.12804 · Cited by 38
“Legro et al, 2015,.(78) RCT N = 149 A: n = 49 B: n = 50 C: n = 50 Infertile women 18‐40yo with PCOS planning pregnancy: BMI 27‐42 kg/m(2).”
BackgroundMethodEffects of obesity treatment on female reproduction: results do not match expectations
Legro, R. S. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.02.109 · Cited by 72
Self-citationXu, W., Tang, M., Wang, J., & Wang, L. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/4086864 · Cited by 35
“In the past few decades, oral contraceptive pills (OCPs) have been widely used in PCOS patients to regulate their menstrual cycles and reduce hyperandrogenism [4].”
BackgroundReducing intergenerational obesity and diabetes risk
Sauder, K. A., & Ritchie, N. D. (2021) · Diabetologia · doi:10.1007/s00125-020-05341-y · Cited by 39
Stener‐Victorin, E., Maliqueo, M. A., Soligo, M., Protto, V., Manni, L., Jerlhag, E., Kokosar, M., Sazonova, A. P., Behre, C. J., Lind, M., et al. (2016) · Obesity Science & Practice · doi:10.1002/osp4.78 · Cited by 35
“Recently, it was demonstrated that lifestyle modification with a targeted weight loss of 7% has beneficial metabolic and reproductive effects (9).”
BackgroundForslund, M., Melin, J., Alesi, S., Piltonen, T., Romualdi, D., Tay, C. T., Witchel, S., Pena, A., Mousa, A., & Teede, H. (2023) · Clinical Endocrinology · doi:10.1111/cen.14913 · Cited by 32
“Results from this RCT indicated improved subjective hirsutism after COCP treatment, as well as decreased testosterone and increased SHBG levels.(39) No differences were evident between the groups regarding sexual function scores, but importantly, no difference was seen in sexual desire or sexual function after COCP tr…”
ResultLiu, Y., Li, J., Yan, Z., Liu, D., Ma, J., & Tong, N. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.657889 · Cited by 39
“6 in Tables), the combined therapy group demonstrated trends toward lower HOMA-IR and higher pregnancy rate compared with the CC monotherapy group, although they were not significant (28).”
BackgroundMethodResultInfluentialNormal Pubertal Development in Daughters of Women With PCOS: A Controlled Study
Legro, R. S., Kunselman, A. R., Stetter, C., Gnatuk, C. L., Estes, S. J., Brindle, E., Vesper, H. W., Botelho, J. C., Lee, P. A., & Dodson, W. C. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2707 · Cited by 34
“, Bedford, MA) as we have previously performed in adults (21).”
MethodSelf-citationScott, D. S., Harrison, C. L., Hutchison, S. K., de Courten, B. V., & Stepto, N. K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182412 · Cited by 39
“For example, a 16-week program of combined caloric restriction, behavioural modification, physical activity, and (for obese women) weight loss medication, resulted in weight loss of over 6% in women with PCOS [22], which is greater than the 2% weight loss observed in our intervention involving exercise only [4].”
BackgroundChang, H., Xie, L., Ge, H., Wu, Q., Yan, W., Zhang, D., Zhang, Y., Ma, H., Gao, J., Wang, C. C., et al. (2019) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2018.12.046 · Cited by 39
Shah, A., Dodson, W. C., Kris‐Etherton, P. M., Kunselman, A. R., Stetter, C., Gnatuk, C. L., Estes, S. J., Allison, K. C., Sarwer, D. B., Sluss, P. M., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa682 · Cited by 37
Self-citationOptimizing reproductive health in women with obesity and infertility
Belan, M., Harnois-Leblanc, S., Laferrère, B., & Baillargeon, J.-P. (2018) · Canadian Medical Association Journal · doi:10.1503/cmaj.171233 · Cited by 29
Vitek, W., & Hoeger, K. M. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.07.001 · Cited by 35
Zhu, J., Hu, M., Liang, Y., Zhong, M., Chen, Z., Wang, Z., Yang, Y., Luo, Z., Zeng, W., Li, J., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34837 · Cited by 42
“However, in patients with polycystic ovary syndrome, orlistat may have an improving effect on menstrual disorders [59].”
BackgroundC-reactive protein and ART outcomes: a systematic review
Brouillet, S., Boursier, G., Anav, M., Boissière, B. D. B. D. L., Gala, A., Ferrières-Hoa, A., Touitou, I., & Hamamah, S. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmaa012 · Cited by 32
Weiss, M. S., Roe, A. H., Allison, K. C., Dodson, W. C., Kris‐Etherton, P. M., Kunselman, A. R., Stetter, C., Williams, N. I., Gnatuk, C. L., Estes, S. J., et al. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.08.1396 · Cited by 36
Self-citationHaase, C. L., Varbo, A., Laursen, P. N., Schnecke, V., & Balen, A. H. (2023) · Human Reproduction · doi:10.1093/humrep/deac267 · Cited by 39
Wekker, V., Huvinen, E., van Dammen, L., Rönö, K., Painter, R. C., Zwinderman, A. H., van de Beek, C., Sarkola, T., Mol, B. W., Groen, H., et al. (2018) · European Journal of Public Health · doi:10.1093/eurpub/cky222 · Cited by 31
Mr. Fertility Authority, Tear Down That Weight Wall!
Legro, R. S. (2016) · Human Reproduction · doi:10.1093/humrep/dew253 · Cited by 25
“android fat is preferentially lost compared to gynoid fat during weight loss (Legro et al., 2012; Legro et al., 2015).”
BackgroundResultSelf-citationKiel, I. A., Lundgren, K., Mørkved, S., Kjøtrød, S., Salvesen, Ø. O., Romundstad, L. B., & Moholdt, T. T. (2018) · BMJ Open Sport & Exercise Medicine · doi:10.1136/bmjsem-2018-000387 · Cited by 34
Liraglutide: New Perspectives for the Treatment of Polycystic Ovary Syndrome
Papaetis, G. S., Filippou, P. K., Constantinidou, K. G., & Stylianou, C. S. (2020) · Clinical Drug Investigation · doi:10.1007/s40261-020-00942-2 · Cited by 25
Scragg, J., Hobson, A., Willis, L., Taylor, K., Dixon, S., & Jebb, S. A. (2024) · Annals of Internal Medicine · doi:10.7326/m23-3179 · Cited by 33
Dokras, A., Playford, M. P., Kris‐Etherton, P. M., Kunselman, A. R., Stetter, C., Williams, N. I., Gnatuk, C. L., Estes, S. J., Sarwer, D. B., Allison, K. C., et al. (2017) · Clinical Endocrinology · doi:10.1111/cen.13310 · Cited by 24
Self-citationPrice, S., Nankervis, A. J., Permezel, M., Prendergast, L. A., Sumithran, P., & Proietto, J. (2018) · Trials · doi:10.1186/s13063-018-2615-6 · Cited by 25
“The fertility benefit of VLED-induced weight loss has already been demonstrated [29, 35, 42, 67].”
BackgroundBader, S., Bhatti, R., Mussa, B. M., & Abusanana, S. (2024) · Women s Health · doi:10.1177/17455057241234530 · Cited by 46
Palomba, S., Costanzi, F., Caserta, D., & Vitagliano, A. (2024) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2024.104381 · Cited by 24
Thomas, S. A., Woo, I., Ho, J. R., Jones, T., Paulson, R. J., Chung, K., & Bendikson, K. A. (2019) · Contraception and Reproductive Medicine · doi:10.1186/s40834-019-0102-4 · Cited by 22
Lindsay, K. L., Milone, G. F., Grobman, W. A., Haas, D. M., Mercer, B. M., Simhan, H. N., Saade, G. R., Silver, R. M., & Chung, J. M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.940870 · Cited by 24
Kim, S. Y., Park, E.-S., & Kim, H. W. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17207438 · Cited by 27
“…Center) In Person 6 months NR 6 months A: BMI, BW B: Pregnancy Rate C: Ovulation (Rate), Menstrual Cycle D: LH, T E: Fasting Insulin, Lipids (TG) Legro et al. (2015) [39] USA Infertility due to PCOS Planning Pregnancy) Age 18–40 BMI 27–42 a: n = 44 Age: a:28.6 BMI: a:35.1 PCOS b: n = 43 c:…”
BackgroundInfluentialBrackenridge, L., Finer, N., Batterham, R. L., Pedram, K., Ding, T., Stephenson, J., Barry, J. A., & Hardiman, P. (2018) · Clinical Obesity · doi:10.1111/cob.12252 · Cited by 21
“(8), women with infertility due to polycystic ovary syndrome, age 18–40 years and BMI 27–42 kg/m(2) were randomized to receive either 16 weeks of continuous combined oral contraception (OCP), lifestyle modification (caloric restriction with meal replacements, weight loss medication [either sibutramine or orlistat] and…”
MethodEdwards‐Hampton, S. A., & Ard, J. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15819 · Cited by 17
“91 Women with overweight or obesity may benefit from life-style interventions that include use of PDR during pregnancy to limit excess gestational weight gain.”
Rubino, F., Logue, J., Bøgelund, M., Madsen, M. E., Cancino, A., Høy, M., & Panton, U. H. (2021) · Obesity Science & Practice · doi:10.1002/osp4.518 · Cited by 21
Dodd, J. M., Deussen, A. R., Mitchell, M., Poprzeczny, A. J., & Louise, J. (2022) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2022.2094366 · Cited by 17
“While the lifestyle intervention was associated with weight loss, no pregnancy outcomes were reported [73].”
Background
Metadata
- Authors
- Legro, R. S., Dodson, W. C., Kris-Etherton, P. M., Kunselman, A. R., Stetter, C. M., Williams, N. I., Gnatuk, C. L., Estes, S. J., Fleming, J., Allison, K. C., Sarwer, D. B., Coutifaris, C., & Dokras, A.
- Affiliations
- Pennsylvania State University (US)
- Corresponding author
- Legro, Richard S.
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-11
- Volume
- 100
- Issue
- 11
- Pages
- 4048-4058
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC4702450
- OpenAlex
- W2142157239
- Cited by
- 242
- References
- 42
- Citations by year
- 2026: 10 · 2025: 22 · 2024: 25 · 2023: 26 · 2022: 30 · 2021: 20 · 2020: 22 · 2019: 17 · 2018: 28 · 2017: 22 · 2016: 18
- FWCI
- 25.89
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Virginia
- Hologic
- National Institutes of Health (UL1TR000127, UL1TR002014)
- National Center for Advancing Translational Sciences
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54-HD29834, R01HD029834, P50HD028934, R01HD056510)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Keywords
- polycystic ovary syndrome, female infertility, preconception interventions, lifestyle modification, weight loss, ethinyl estradiol, clomiphene citrate, ovulation induction, live birth, metabolic syndrome, obesity, sibutramine, orlistat, physical activity, caloric restriction, meal replacement, pregnancy outcomes, ovulation
- MeSH terms
- Adult, Behavior Therapy, Birth Rate, Clomiphene, Combined Modality Therapy, Diet, Reducing, Drug Resistance, Female, Fertility Agents, Female, Humans, Infertility, Female, Life Style, Motor Activity, Obesity, Ovulation Induction, Pennsylvania, Polycystic Ovary Syndrome, Pregnancy, Body Mass Index, Prevalence, Preconception Care, Pregnancy Rate, Anti-Obesity Agents, Metabolic Syndrome, Overweight
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.